BMS acquisition of Turning Point Therapeutics at US$4.1 B closed on 8/15/2022
Applied Biocode is selected top 10 leading molecular diagnostics cos to watch in 2022 by C10 Insight
Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company
逸達前列腺癌新劑型新藥 CAMCEVI 42 毫克獲加拿大上市許可
Alamar Biosciences Completes $80M Series B Fundraising to Bring UnprecedentedPerformance to the Pro
Turning Point Therapeutics Granted FDA Orphan Drug Designation for TPX-0022 in Gastric Cancer
EUREKA THERAPEUTICS ANNOUNCES INITIATION OF PHASE I/II ARYA-3 CLINICAL TRIAL OF GPC3 TARGETING ARTEM
林允進打造庶民遊艇,分享開發平民化遊艇之心得
般若科技 船用螺旋槳挺進全球
全球首創「Adonit INK-M 雙效能觸控滑鼠筆」是觸控筆也是滑鼠,給你的Surface平板更靈活全面的應用
升級支援壓力感應 Adonit推出Note+ 專業版觸控筆
眾智點火三引擎 Q3申請上櫃
把美系電競筆電廠養成帶路雞!眾智光電預計將拿下5大客戶,下一步瞄準耳溫傳感藍牙耳機市場
Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI® for the Treatment of Advanced Prostate C
物聯智慧雲端服務營收續強 近期並取得陸中移物聯戰略合作
物聯智慧雲端服務營收續強 取得陸戰略合作
榮炭大股東 個個有來頭
GIS、碩禾入股負極材料廠榮炭
疫情間客戶數10倍速成長!用LINE點餐的「快一點」,如何成早餐店阿姨的好幫手?
不用再排隊點餐!點點全球協助餐飲數位轉型,用Line就可以點餐
No. 187, Section 2, Tiding Boulevard, Neihu District, 114
Taipei City, Taiwan
+886-2-26579368
© 2021 by Harbinger Venture Capital.